CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

Western licensing deals for Chinese radioligand therapies to jump in 2027, Sleuth forecasts

PartnershipNeutral
AI Analysis

Summary

Sleuth forecasts an increase in Western licensing deals for Chinese radioligand therapies in 2027, noting that such deals have been rare historically with a limited pool of potential Western buyers.

Importance:2/10
Sentiment:
0.00
radiopharmaceuticalsradioligand_therapylicensingChinese_biotechWestern_market

Read the original article

Published by BioSpace on September 21, 2026 4:21 PM

Read Original